Stock Price Quote

GUJARAT THEMIS BIOSYN LTD.

NSE : GUJTHEMBSE : 506879ISIN CODE : INE942C01045Industry : Pharmaceuticals & DrugsHouse : Private
BSE413.451.9 (+0.46 %)
PREV CLOSE ( ) 411.55
OPEN PRICE ( ) 413.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18163
TODAY'S LOW / HIGH ( )402.00 420.60
52 WK LOW / HIGH ( )225.75 479.45
NSE413.201.55 (+0.38 %)
PREV CLOSE( ) 411.65
OPEN PRICE ( ) 415.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 137723
TODAY'S LOW / HIGH( ) 401.55 420.00
52 WK LOW / HIGH ( )225.05 479
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1981
Management Info
Dinesh S Patel - Chairman Sachin D Patel - Managing Director
Registered Office

Address 69 / C,G I D C Industrial Estate,Vapi,
Valsad Dist,
Gujarat-396195

Phone 0260-2430027 / 2400639

Email hrm@gtbl.in.net

Website www.gtbl.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

05Jun Gujarat Themis Biosyn informs about ou
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclo..
23May Gujarat Themis Biosyn signs definitive
Gujarat Themis Biosyn has signed definitive agreement for the acquisitio..
21May Preferential Issue of Shares
Preferential Issue of shares & Final Dividend & Audited Results
24Apr Gujarat Themis Biosyn to acquire Sanof
Gujarat Themis Biosyn has signed asset purchase agreement to acquire a p..
24Apr Gujarat Themis Biosyn soars on signing
Gujarat Themis Biosyn is currently trading at Rs. 330.25, up by 7.30 poi..

Financials

in Millions
QTR Mar 26 ANNUAL 26
Net Profit108.91466.82
Gross Profit 143.37 620.9
Operating Profit 202.81779.58
Net Sales 442.331658.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26017.65 (0.71%)
M.Cap ( in Cr)55285.69
Acutaas Chemicals (BSE)
peergroup  3328.40 (5.20%)
M.Cap ( in Cr)27249.98
NGL Fine-Chem (BSE)
peergroup  2735.15 (5.73%)
M.Cap ( in Cr)1689.78
Astrazeneca Pharma I (BSE)
peergroup  8598.60 (1.20%)
M.Cap ( in Cr)21496.50
Torrent Pharma (BSE)
peergroup  4418.70 (1.87%)
M.Cap ( in Cr)149548.89

Shareholding Pattern

PROMOTERS 70.86%
NON-INSTITUTION 26.16%
MUTUAL FUNDS/UTI 1.16%
FI/BANKS/INSURANCE 0.01%
GOVERNMENT 0%
FII 0%

About Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd. was incorporated in the year 1981. Its today's share price is 413.45. Its current market capitalisation stands at Rs 4505.17 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1508 Cr and Total Income of Rs.1532.32 Cr. The company's management includes Rajneesh Anand, Nihar Parikh, KG Ananthakrishnan, Hitesh Gajaria, Kirandeep Kaur Madan, Sachin D Patel, Dinesh S Patel, Vineet G Gawankar.

It is listed on the BSE with a BSE Code of 506879 , NSE with an NSE Symbol of GUJTHEM and ISIN of INE942C01045. It's Registered office is at 69 / C,G I D C Industrial Estate,VapiValsad Dist-396195, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are GMJ & Co, Khandelwal Jain & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.